Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding
- 10 December 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 209 (1-2) , 27-32
- https://doi.org/10.1016/0014-2999(91)90006-c
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteriesNeuropeptides, 1990
- Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnessesActa Psychiatrica Scandinavica, 1990
- The anti-inflammatory effects ofd-myo-inositol-1.2.6-trisphosphate (PP56) on animal models of inflammationInflammation Research, 1990
- Inositol phosphates and cell signallingNature, 1989
- Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety modelsPsychopharmacology, 1989
- Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptorsEuropean Journal of Pharmacology, 1988
- Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons.Proceedings of the National Academy of Sciences, 1988
- Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the ratRegulatory Peptides, 1987
- Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the ratEuropean Journal of Pharmacology, 1987
- Neuropeptide Y distribution in human brainNature, 1983